Rohrer, K.A.; Song, H.; Akbar, A.; Chen, Y.; Pramanik, S.; Wilder, P.J.; McIntyre, E.M.; Chaturvedi, N.K.; Bhakat, K.K.; Rizzino, A.;
et al. STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo. Cancers 2023, 15, 2239.
https://doi.org/10.3390/cancers15082239
AMA Style
Rohrer KA, Song H, Akbar A, Chen Y, Pramanik S, Wilder PJ, McIntyre EM, Chaturvedi NK, Bhakat KK, Rizzino A,
et al. STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo. Cancers. 2023; 15(8):2239.
https://doi.org/10.3390/cancers15082239
Chicago/Turabian Style
Rohrer, Kyle A., Heyu Song, Anum Akbar, Yingling Chen, Suravi Pramanik, Phillip J. Wilder, Erin M. McIntyre, Nagendra K. Chaturvedi, Kishor K. Bhakat, Angie Rizzino,
and et al. 2023. "STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo" Cancers 15, no. 8: 2239.
https://doi.org/10.3390/cancers15082239
APA Style
Rohrer, K. A., Song, H., Akbar, A., Chen, Y., Pramanik, S., Wilder, P. J., McIntyre, E. M., Chaturvedi, N. K., Bhakat, K. K., Rizzino, A., Coulter, D. W., & Ray, S.
(2023). STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo. Cancers, 15(8), 2239.
https://doi.org/10.3390/cancers15082239
